FOSFOCINE 4 g I.V., powder for solution for infusion bottle
Active ingredients: Fosfomycin, Fosfomycin sodium
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder for solution for infusionbottleintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FOSFOCINE 4 g I.V., poudre pour solution pour perfusion
- Pharmaceutical form
- poudre pour solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s)
- Marketing authorisation holder
- SANOFI AVENTIS FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Aug 2022
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60150232CIP72179121CIP133400921791211Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FOSFOMYCINE SODIQUEpoudre | — | SA |
| FOSFOMYCINEpoudre | 4 g · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.